| (HKD) | Dec 2024 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 39.73M | -63.42% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 1349.HK returned -32.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -7.2% |
| 1 year | -32.7% |
| 5 years | -30.7% |
| 10 years | -57.9% |
| All-time high | $10.30 (May 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 1349.HK would be worth today ›No. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. has not paid a dividend in the past 12 months.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. is part of the Healthcare sector.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. has a market cap of 2.66B HKD, based on the latest quote.
